Countdown

  • SENSEX
    NIFTY 50
Business

Biocon share price shoots up on Q1 numbers and biologics business

Updated : July 27, 2018 04:11 PM IST

Biocon's contract research and manufacturing arm, Syngene International, reported a 39 percent YoY growth.
Biocon–Mylan received approval for two biosimilar drugs pegfilgrastim and trastuzumab in the past seven months, marking their entry in to the coveted US biosimilar market.
Biocon share price shoots up on Q1 numbers and biologics business
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV